Covid vaccine: Breakthrough as Pfizer and BioNTech jab found to offer '90 per cent protection'
Phase-3 trials by the American firm and its German partner involved more than 43,000 people
Daniel Bardsley
09 November, 2020
- Listen In English
- Listen In Arabic